1. Introduction {#sec1-molecules-25-03099}
===============

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most popular pharmaceuticals that have been used against inflammation, pain, and fever over the years \[[@B1-molecules-25-03099]\]. Their therapeutic effect is mainly based on their ability to inhibit the conversion of the arachidonic acid to prostaglandins \[[@B2-molecules-25-03099]\]. Unfortunately, NSAIDs exhibit acute side effects and may cause dyspepsia, nausea, abdominal pain, constipation, headache, dizziness, and rash \[[@B2-molecules-25-03099],[@B3-molecules-25-03099]\]. Additionally, several NSAIDs can be effectively applied in treatments of colon, lung, and breast cancers \[[@B4-molecules-25-03099],[@B5-molecules-25-03099]\] due to their profound chemopreventive and chemosuppressive effects \[[@B6-molecules-25-03099],[@B7-molecules-25-03099],[@B8-molecules-25-03099]\].

The structural similarity of crystals \[[@B9-molecules-25-03099]\] plays a vital role in understanding the pharmaceutical activity of solid-state drugs. It is often described by the term isostructurality \[[@B10-molecules-25-03099]\] and is profoundly associated with intermolecular interactions and often prompted by symmetry restrictions. A given packing arrangement may tolerate tiny molecular geometry adjustments while keeping the crystals almost isostructural \[[@B11-molecules-25-03099],[@B12-molecules-25-03099]\]. However, certain crystals of coordination compounds which diverse metal ions are characterized by the same chemical constituents may not be classified as entirely isostructural due to subtle differences in their interaction arrangement \[[@B13-molecules-25-03099]\]. That quasi-isostructurality was observed in systems **3** and **4**.

Mefenamic acid (2-(2,3-dimethylphenyl)aminobenzoic acid) **1** was discovered by Claude Winder from Parke--Davis in 1961 and successively introduced into the market as an NSAID three years later \[[@B14-molecules-25-03099],[@B15-molecules-25-03099]\]. It belongs to the group of anthranilic acid derivatives also known as fenamates \[[@B16-molecules-25-03099],[@B17-molecules-25-03099]\]. Nowadays, it is widely used as an analgesic and antipyretic agent characterized by mild side-effects and applied in treatments of osteoarthritis, rheumatoid arthritis, and other painful musculoskeletal illnesses \[[@B18-molecules-25-03099],[@B19-molecules-25-03099]\].

Mefenamic acid adopts three distinctive polymorphic forms, denoted as I, II, and III \[[@B20-molecules-25-03099],[@B21-molecules-25-03099]\]. They show diverse solubilities and stabilities \[[@B22-molecules-25-03099],[@B23-molecules-25-03099]\]. Form I is the most stable under ambient conditions, II is stable above 160 °C, and III is the least stable and converts back to I \[[@B22-molecules-25-03099]\]. The crystal structures of I, II, and III were reported in 1976, 2008, and 2012, respectively \[[@B22-molecules-25-03099],[@B23-molecules-25-03099],[@B24-molecules-25-03099],[@B25-molecules-25-03099]\]. Mefenamic acid belongs to Class II of the Biopharmaceutical Classification System \[[@B26-molecules-25-03099]\] and is characterized by a relatively low solubility and high permeability, both of which hamper its clinical use \[[@B22-molecules-25-03099]\]. Its metal complexes may overcome this deficiency. In fact, considerable attention has been paid to transition metal complexes with active drugs \[[@B2-molecules-25-03099],[@B27-molecules-25-03099]\]. Those studies showed that several properties, like solubility, reactivity, and stability, are different than those determined for the ligand or metal alone \[[@B28-molecules-25-03099],[@B29-molecules-25-03099]\]. Metal complexes of fenamates, including those with mefenamic acid, have been recently investigated. Most of them have shown improved biological activities compared to the sole drugs \[[@B3-molecules-25-03099],[@B30-molecules-25-03099],[@B31-molecules-25-03099]\] and revealed interesting antibacterial, antifungal, analgesic, and anti-inflammatory applications.

Additionally, a number of crystal structures of metal--mefenamato complexes have been reported. In particular, a series of Mn(II) \[[@B3-molecules-25-03099],[@B32-molecules-25-03099]\], Co(II) \[[@B33-molecules-25-03099]\], Ni(II) \[[@B34-molecules-25-03099]\], Cu(II) \[[@B35-molecules-25-03099],[@B36-molecules-25-03099],[@B37-molecules-25-03099]\], Zn(II) \[[@B38-molecules-25-03099]\], and Sn(IV) \[[@B39-molecules-25-03099]\] complexes showed that mefenamato ligands may be involved in diverse coordination modes.

The synthesis, spectroscopic properties, and thermal stability of six divalent mefenamato complexes Mn(mef)~2~∙3H~2~O **5**, Co(mef)~2~∙2H~2~O **6**, Ni(mef)~2~∙2H~2~O **7**, Cu(mef)~2~∙2H~2~O **8**, Zn(mef)~2~∙2H~2~O **9**, and Cd(mef)~2~∙2H~2~O **10** were described by us previously \[[@B40-molecules-25-03099]\]. In this contribution, we report the successful crystallization and crystal structures of three mefenamato complexes: **2**--**4** ([Scheme 1](#molecules-25-03099-sch001){ref-type="scheme"}). Furthermore, the high quality and low temperature structure of **3** was also determined and compared to the already published by Dimiza et al. structure of \[Co(mef)~2~(MeOH)~4~\]∙2MeOH \[[@B33-molecules-25-03099]\]. The latter is characterized by exceptionally high uncertainty ellipsoids of oxygen atoms directly linked to the central cobalt ions. Therefore, we redetermined the structure of **3** through a single crystal X-ray analysis. The high quality data, collected at a temperature T = 100 K, allowed us to define and refine all disordered atoms and provided precise atomic coordinates further used in this work. In addition, the spectral, thermal, antioxidant, and antimicrobial properties of **1**--**4** were determined and compared to the series of **5**--**10**.

2. Results and Discussion {#sec2-molecules-25-03099}
=========================

Compounds **2**, **3**, and **4** are air stable at room temperature. They are highly soluble in polar organic solvents like DMF, DMSO, methanol, and ethanol. Their properties were thoroughly investigated by the FAAS, EA, FTIR, and TGA methods augmented by antimicrobial and antioxidant studies; see [Table 1](#molecules-25-03099-t001){ref-type="table"}. The crystal structures of **2**--**4** were determined by the single crystal X-ray diffraction technique; see [Table 2](#molecules-25-03099-t002){ref-type="table"}. The crystals of **3** and **4** are isomorphic. The analytical data were in good agreement with crystal structures of all complexes.

2.1. Description of Crystal Structures {#sec2dot1-molecules-25-03099}
--------------------------------------

### 2.1.1. Crystal Structure of **2** {#sec2dot1dot1-molecules-25-03099}

The molecular structure of complex **2** is presented in [Figure 1](#molecules-25-03099-f001){ref-type="fig"}. It crystallizes in the triclinic space group P$\overline{1}$ with two symmetrically independent cobalt ions, namely Co1 and Co2, placed in a special positions on inversion centers. Therefore, the single asymmetric unit contains half Co1 and half Co2 ions, two mefenamato moieties, two coordinated waters, and a single coordinated ethanol molecule. Both Co(II) ions are six coordinated, adopt octahedral environments, and share a single apical water O5. This arrangement propagates along the \[100\] direction, thus leading to a 1-D polymeric structure with a Co1--O5--Co2 repetitive unit ([Figure S1](#app1-molecules-25-03099){ref-type="app"}). Similar supramolecular motifs were recently identified and published by us \[[@B2-molecules-25-03099]\].

Both mefenamato ligands are monodentate with coordinating carboxylate O1 and O3 atoms placed in equatorial positions of Co1 and Co2, respectively. Ethanol O7, as in Co1, and water O6, as in Co2, complete cobalt coordination spheres. The two 2-((2,3-dimethylphenyl)amino)benzoate moieties adopt twisted conformations. The dihedral angles between phenyl rings are 82.65(16) and 38.55(11)° for the species coordinated to Co1 and Co2, respectively. The apical Co1--O5 and Co2--O5 bonds distances are almost identical (2.1518(15) and 2.1493(15) Å, respectively) and are longer than Co--O bonds placed in equatorial positions (2.0454(15)-2.0973(17) Å).

The presented crystal is stabilized by an extensive network of inter- and intramolecular hydrogen bonds ([Table 3](#molecules-25-03099-t003){ref-type="table"}). In particular, a strong intramolecular interaction is formed between a sole hydrogen at the coordinating water molecule O6 and the carboxylate O1 of a mefenamato moiety. The hydrogen of the ethanol O7 molecule participates in a hydrogen bond with the carboxylate O3. Moreover, the O5 water molecules are hydrogen donors to bifurcated carboxylate acceptors O2 and O4, and the latter oxygen atoms additionally attract hydrogens of neighboring amine groups N1 and N2A, respectively. The resulting chain motif may be described by the Etter's symbol $C_{4}^{2}\left( 9 \right)$ \[[@B41-molecules-25-03099],[@B42-molecules-25-03099]\].

### 2.1.2. Crystal Structure of **3** and **4** {#sec2dot1dot2-molecules-25-03099}

The centrosymmetric, triclinic crystals of **3** and **4** ([Figure 2](#molecules-25-03099-f002){ref-type="fig"}) are quasi-isostructural \[[@B43-molecules-25-03099]\]. Their asymmetric units contain one-half metal ions, a single mefenamato ligand, two coordinated methanol species, and an additional methanol molecule in the outer coordination sphere. The inner coordination spheres of both complexes are quite similar. Octahedral metal ions are placed on inversion centers. They are surrounded by two equatorial mefenamato carboxylate oxygen atoms augmented by two equatorial and two apical methanol molecules. Similarly to **2**, the 2-((2,3-dimethylphenyl)amino)benzoate moieties in **3** and **4** adopt twisted conformations with dihedral angles between phenyl rings equal 74.60(3) and 74.38(18)°, respectively. Apical Co--O3A (2.1220(15) Å) and Ni--O3B (2.113(3) Å) bonds involving methanol species are longer than relevant equatorial bonds (Co--O4A and Ni--O4B; 2.0803(13) and 2.051(2) Å, respectively). The equatorial coordination bonds involving the carboxylate O1 atoms of the mefenamato moieties are slightly shorter (2.0556(8) and 2.0207(8) Å for **3** and **4**, respectively). A structurally similar complex (Mn(mef)~2~(MeOH)~4~) was recently reported by Feng et al. \[[@B32-molecules-25-03099]\]. Following the larger atomic radius of manganese, all bonds within the Mn coordination sphere of this compound are longer than the respective bonds observed in **3** and **4**.

The quasi-isostructurality of **3** and **4** is driven by the diverse topologies of the strong hydrogen bonds in both crystals; see [Table 4](#molecules-25-03099-t004){ref-type="table"} and [Table 5](#molecules-25-03099-t005){ref-type="table"}, respectively. The superposition of both structures is presented in [Figure 3](#molecules-25-03099-f003){ref-type="fig"}. In **3**, the carboxylate O2 of the mefanamato moiety is involved in hydrogen bonding with the O4 equatorial methanol molecule. The O5 methanol of the outer coordination sphere is connected to the axial O3. A diverse situation is observed in **4,** where carboxylate O2 interacts with axial O3, while equatorial O4 is involved in H bonding with O5. The latter is a hydrogen donor for contact with carboxylate O2 in either **3** or **4**. The resulting chain may be characterized by motif $C_{3}^{3}\left( 7 \right)$ ([Figure S2](#app1-molecules-25-03099){ref-type="app"}). The conformation of mefanamato moieties in all investigated complexes **2**--**4** is stabilized by the intramolecular interactions of the amine nitrogen atoms with carbonyl groups.

### 2.1.3. Crystal Packing Analysis of **2--4** {#sec2dot1dot3-molecules-25-03099}

The molecular shapes of structures **2**--**4** were visualized as Hirshfeld surfaces (HSs) ([Figure 4](#molecules-25-03099-f004){ref-type="fig"}). In **2**, the mer unit of infinite polymeric chain was selected for the HS visualization. Relevant fingerprint plots (FPs) derived from the HSs were generated for each structure to characterize the propensity of these species to form particular intermolecular contacts. Crystal packing arrangements in all structures may be defined by three types of contacts, namely H^...^H, C^...^H, and O^...^H. Additionally, the fingerprint analysis revealed the limited presence of N^...^H contacts, as indicated by their contributions below 1%. Due to the polymeric character of **2**, the H^...^H contacts contribution of 63.7% is notably lower than that in **3** and **4**. The latter approach 70.2% and 70.4%, respectively. The FPs of all systems feature symmetrical wings that visualize C^...^H contacts and follow the C--H^...^π and O--H^...^π interactions. The contribution of C^...^H contacts in the crystal packing is visibly higher for polymeric structure **2** (26.2%) than those in **3** and **4** (21.9% and 22.4%, respectively). Similarly, the O^...^H contacts contributions over all structures range from 7.0% to 8.2%. These contacts are depicted as sharp spikes for **2**, while for **3** and **4**, those spikes are slightly bold. The latter presumable follow the methanol molecule disorder in the crystal structures of **3** and **4**. Interestingly, a difference in the intermolecular hydrogen bond topology is also apparent in the O^...^H contact contribution. Structure **3**, where axial O3 is a hydrogen donor for the outer O5 methanol, is characterized by an O^...^H contacts contribution of 7.0%. The equatorial position of the relevant hydrogen bond donor in **4** results in an increase of the O^...^H contacts' contribution to 7.7%.

The fingerprint analysis showed that supramolecular systems of **2**--**4** are defined by a relatively similar set of contacts. The most distinguished is a polymeric system in **2**. Nonetheless, the quantitative analysis of intermolecular contacts helped to expose the subtle differences in supramolecular assemblies, as observed in the quasi-isostructural systems of **3** and **4**.

2.2. Infrared Spectra of **2--4** {#sec2dot2-molecules-25-03099}
---------------------------------

All complexes exhibit sharp bands in the range of 3290--3305 cm^−1^ and weak broad absorption bands in the region of 2900--3200 cm^−1^ associated with the ν(NH) and ν(OH) stretching vibrations, respectively ([Figure S3](#app1-molecules-25-03099){ref-type="app"}). Additionally, bands at 3610--3630 cm^−1^ for **3** and **4** are assigned to the ν(OH) stretching vibration of methanol molecules. The characteristic bands originated from carboxylate group appear in the range of 1350--1700 cm^−1^. In particular, sharp absorption peaks appearing at 1610.3, 1604.5, and 1604.5 cm^−1^ correspond to ν~as~(COO^--^) and peaks at 1380.8, 1382.8, and 1384.3 cm^−1^ are assigned to ν~s~(COO^--^) stretching vibrations of carboxylate group for **2**, **3**, and **4**, respectively. The parameter ∆ν=ν~as~(COO^--^) -- ν~s~(COO^--^) is larger than that for sodium mefenamate \[[@B40-molecules-25-03099]\], and according to Nakamoto \[[@B44-molecules-25-03099]\], the criteria the coordination mode of carboxylate groups may be described as monodentate.

2.3. Thermal Analysis of **2--4** {#sec2dot3-molecules-25-03099}
---------------------------------

The TG/DTG/DTA curves of **2**, **3**, and **4** are summarized in [Figure 5](#molecules-25-03099-f005){ref-type="fig"}. The decomposition pathways are slightly different for each complex. Compound **2** starts to decompose through the concurrent elimination of the ethanol molecule together with two water molecules (mass loss exp. 12.70% and calc. 13.23%) proceeding at the temperature range of 80--250 °C. It is accompanied by endo- and exo-thermic effects on the DTA curve. The next step represents the mass loss (exp. 12.70% and calc. 13.23%) associated with the destruction of two mefenamate ligands at the temperature range of 250--480 °C. The latter leads to the final product Co~3~O~4~ (exp. 12.93% and calc. 12.57%). The corresponding two endo-thermic and one exo-thermic effects were also identified and are shown on the DTA curve.

The thermal decomposition of **3** and **4** begins with the release of methanol molecules. In **3**, it proceeds in one step, while two distinguished steps were identified for **4**. The weight loss of the former (exp. 26.04% and calc. 26.27%) at 60--260 °C is consistent with the elimination of six methanol molecules altogether. In **4**, two methanol molecules are lost at the temperature range of 100--180 °C (exp. 9.87% and calc. 8.76%), while further four molecules are released at 180--430 °C (exp. 18.13% and calc. 17.52%). The DTA curves exhibit characteristic exo-effects related to those steps. In **4**, both symmetry-related O5 methanols from the outer coordination sphere form weaker hydrogen bonds with the carbonyl O2 than the relevant molecules in **3** ([Table 4](#molecules-25-03099-t004){ref-type="table"} and [Table 5](#molecules-25-03099-t005){ref-type="table"}, respectively). Presumably, the former facilitates a two-step methanol elimination with premature O5 release, as observed in **4**.

Further heating leads to the destruction of both mefenamato moieties in a single step. The experimental weight losses were 62.89% (calc. 62.76%) and 61.77% (calc. 63.51%) for **3** and **4**, respectively. The corresponding exo- and endo-thermal effects are visible on relevant DTA curves. The final products of thermal decompositions are Co~3~O~4~ for **3** and NiO for **4**. Their experimental residual masses (Co~3~O~4~: 11.07%; NiO: 10.28%) were close to calculated values (Co~3~O~4~: 10.97%; NiO: 10.21%).

2.4. Antioxidant and Antimicrobial Activities {#sec2dot4-molecules-25-03099}
---------------------------------------------

The antibacterial, antifungal, and antioxidant activities were determined for complexes **2**--**4** and, additionally, **5**--**10** published by us \[[@B40-molecules-25-03099]\]. The above three activities were also analyzed, for the mefenamic acid **1** taken as a reference.

The investigated complexes exhibited visible RSAs (i.e., higher than that of **1**), with those of **5**, **4**, **2**, and **8** being the highest. The final antioxidant activities are in the order of **5** \> **4** \> **2** \> **8** \> **3** \> **7** \> **9** \> **10** \> **6** ([Figure 6](#molecules-25-03099-f006){ref-type="fig"}). Similar results were reported by Altun and Suözer \[[@B45-molecules-25-03099]\], who pointed out that the electron withdrawing effect of the metal(II) ion facilitates the release of hydrogen, which further reduces the DPPH radical.

The results of the antibacterial and antifungal activities are presented in [Table 6](#molecules-25-03099-t006){ref-type="table"}. Vancomycin (Van) and nystatin (Nys) were used as the standard drugs. Notably, the tested derivatives showed no bioactivity against Gram-negative bacteria (*E. coli* ATCC 25922, *S.* Typhimurium ATCC 14028, *K. pneumoniae* ATCC 13883, *P. aeruginosa* ATCC 9027, and *P. mirabilis* ATCC 12453) with minimal inhibition concentrations (MIC) (MIC 500 -- \>1000 mg/L). The MIC values for Gram-positive reference bacteria indicated the good (MIC 26--125 mg/L) or moderate (MIC 126--500 mg/L) anti-staphylococcal (*S. aureus* ATCC 25923 and *S. epidermidis* ATCC 12228), anti-micrococcal (*M. luteus* ATCC 10240), and anti-streptococcal (*S. pyogenes* ATCC 19615, *S. pneumonia* ATCC 49619, and *S. mutans* ATCC 25175) activity of the tested compounds \[[@B46-molecules-25-03099]\]. The antibacterial efficiency of the tested derivatives was in the order of **10** \> **3** \> **2** \> **6** \> **4** \> **9** \> **7** \> **5** \> **8** \> **1**. The antifungal bioactivity (*C. albicans* ATCC 2091, *C. glabrata* ATCC 90030, and *C. parapsilosis A*TCC 22019) of the tested compounds was mild or moderate, with that of **10** being the highest.

3. Experimental {#sec3-molecules-25-03099}
===============

3.1. Preparation of Complexes and Crystallization {#sec3dot1-molecules-25-03099}
-------------------------------------------------

Compounds **2**, **3**, and **4** were synthesized by the dissolution of mefenamic acid (1 mmol) in 50 mL of a freshly precipitated aqueous-ethanol solution (1:1) of NaOH (0.02 mol·L^−1^). Further, sodium mefenamate was heated up to 60 °C and slowly added to an aqueous solution of metal chlorides (0.5 mol in 25 mL). The reaction mixture was kept at 60 °C for 2 hours. After several days, the polycrystalline powders were isolated by filtration, washed with a hot water, and dried in air \[[@B40-molecules-25-03099]\].

Single crystals of the **2**, **3**, and **4** complexes suitable for X-ray structure analysis were obtained at room temperature by slow evaporation from the aqueous/ethanol (1:2 *v*/*v*) solution for **2** and from a pure methanol for **3** and **4**. Good quality crystals appeared after two weeks.

3.2. Materials and Methods {#sec3dot2-molecules-25-03099}
--------------------------

Mefenamic acid was purchased from Sigma-Aldrich and used without further purification. Methanol, ethanol, and DPPH (2,2-diphenyl-1-picrylhydrazyl) were purchased from Lab-Scan, and other chemicals were from POCh---Gliwice, Poland. All reagents were chemically pure.

The chemical compositions of **2**--**4** were determined by the elemental analysis (EA) and flame atomic absorption spectrometry (FAAS). Initially, samples (20 mg) were mineralized by the Anton Paar Multiwave 3000 closed microwave system; a mixture of concentrated HNO~3~ and HCl (6:1, *v*/*v*) was applied. Metals concentration were measured by the FAAS with the GBC Scientific Equipment 932 Plus spectrometer. Hydrogen, carbon, and nitrogen contents were measured with the Vario EL III Elemental Analyzer.

The infrared spectra of **2**--**4** were recorded with the Thermo Scientific Nicolet 6700 FTIR spectrometer equipped with liquid nitrogen-cooled MCT (mercury cadmium telluride---HgCdTe) detector. Samples were prepared as KBr pellets and measured over the range of 4000--400 cm^−1^.

The thermal stability and decomposition pathways of **2**--**4** were studied by thermogravimetric techniques. All complexes were measured with a Netzsch TG 209 apparatus. Samples (10 mg) were heated (in ceramic crucibles) up to 1000 °C at a heating rate 10 °C min^−1^ in an air atmosphere.

The single-crystal X-ray diffraction experiments of **2**--**4** were performed on a Rigaku XtaLAB Synergy Dualflex Pilatus 300K diffractometer. Measurements were conducted using PhotonJet microfocus X-ray source CuK*α* (λ = 1.54184 Å) for **2**, while MoK*α* (λ = 0.71073 Å) radiation was used for **3** and **4**. Crystals were kept at 100.0(1) K during data collection. The data were integrated using the CrysAlisPro software \[[@B47-molecules-25-03099]\]. All structures were solved using the intrinsic phasing method in ShelXT \[[@B48-molecules-25-03099]\] and refined by the full matrix least squares minimization on *F*^2^ with the ShelXL \[[@B49-molecules-25-03099]\] refinement package. The structure of **2** was refined as a two-component twin with a twin scale factor of 0.458(1). The structures of **2**--**4** were notably affected by static disorder, with the mefenamato fragments being disordered over two positions. Relevant occupancy factors were refined to 0.52(3):0.48(3) in **2**, 0.678(3):0.322(3) in **3**, and 0.527(1):0.473(1) in **4**. In **3**, coordinated and non-coordinated methanol molecules were also disordered over two orientations with occupancy factors refined to 0.678(3):0.322(3) and 0.61(2):0.39(2), respectively Similarly, in **4**, methanol molecules were refined over 2 positions, thus resulting in an occupancy factor of 0.591(3):0.409(3). In all structures, the sums of occupancies of relevant sites were set equal to 1 and refined using free variables. The PART instruction was applied to exclude bonding between equivalent disordered atoms. The anisotropic displacement parameters of neighboring disordered atoms were restrained using the SIMU and RIGU procedures in ShelXL. In **2** and **4**, a few disordered atoms were additionally fixed with the EADP instruction. The geometries of disordered fragments were restrained using the DFIX and SADI commands, while O--H and N--H hydrogen atoms were located in difference Fourier maps, C--H hydrogens were generated geometrically using the HFIX command, and a riding model was applied for the refinement. Molecular plots and packing diagrams were drawn using Mercury \[[@B50-molecules-25-03099]\]. Geometry parameters were computed with PLATON \[[@B51-molecules-25-03099]\].

The CIF file for **2**--**4** is available from the Cambridge Crystallographic Data Centre (CCDC) (deposition numbers CCDC: 1989350, 1989353, and 1989354, respectively). Hirshfeld surfaces (HSs) were generated using the CrystalExplorer17 program. Molecular geometries were the same as in crystal structures. For molecular fragments where crystallographic disorder was identified, the major components were only considered. The distances from the HS to the nearest atom interior and exterior to the surface (di and de, respectively) were calculated and plotted as scattergrams \[[@B52-molecules-25-03099]\]. A quantitative decomposition analysis of atom-to-surface contacts was calculated as a percentage of the points in the Hirshfeld surface with di and de for specific atom pairs.

The radical scavenging activities (RSAs) of **1**--**10** were evaluated by measuring scavenging ability of the DPPH free radical. The solutions were prepared as following: 0.5 mL methanolic solutions of the complexes (0.04, 0.06, 0.08, and 0.1 mol/L) were mixed with the DPPH methanolic solution (60 μM and 0.5 mL) in the dark. The samples were incubated at 25 °C for 30 min in the dark to reach equilibrium before the measurement. The radical scavenging ability of compounds was calculated using the equation: I% = (1 − A~s~/A~0~) × 100, where A~0~ is the absorbance of the sample at 0 min and A~S~ is the absorbance of the sample at 30 min. The RSA experiment was repeated in triplicate. The average values were noted.

The antibacterial and antifungal activities were screened for **1**--**10** via the micro-dilution broth method according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) using a Mueller--Hinton broth and a Mueller--Hinton broth with 5% lysed sheep blood for the growth of non-fastidious and fastidious bacteria, respectively, or RPMI with MOPS for the growth of fungi. The minimal inhibitory concentrations (MIC) of the tested derivatives were evaluated for the panel of the reference microorganisms from the American Type Culture Collection (ATCC), including Gram-negative bacteria (*Escherichia coli* ATCC 25922, *Salmonella* Typhimurium ATCC14028, *Klebsiella pneumoniae* ATCC 13883, *Pseudomonas aeruginosa* ATCC 9027, and *Proteus mirabilis* ATCC 12453), Gram-positive bacteria (*Staphylococcus aureus* ATCC 25923, *Staphylococcus epidermidis* ATCC 12228, *Micrococcus luteus* ATCC 10240, *Enterococcus faecalis* ATCC 29212 *Bacillus subtilis* ATCC 6633, *Bacillus cereus* ATCC 10876*, Streptococcus pyogenes* ATCC 19615, *Streptococcus pneumoniae* ATCC 49619, and *Streptococcus mutans* ATCC 25175), and fungi (*Candida albicans* ATCC 10231, *Candida parapsilosis* ATCC 22019, and *Candida glabrata* ATCC 90030).

The complexes dissolved in DMSO were first diluted to the concentration of 1000 mg/L in an appropriate broth medium recommended for bacteria or yeasts. Then, using the same media, serial two-fold dilutions were made in order to obtain final concentrations of the tested derivatives ranged from 1.95 to 1000 mg/L. The sterile 96-well polystyrene microtitrate plates (Nunc, Denmark) were prepared by dispensing 200 µL of the appropriate dilution of the tested derivatives in broth medium per well. The inocula were prepared with fresh microbial cultures in sterile 0.85% NaCl to match the turbidity of 0.5 McFarland standard, and 2 μL were added to wells to obtain a final density of 1.5 × 10^6^ CFU/mL for bacteria and 5 × 10^4^ CFU/mL for yeasts; CFU---colony forming units. After incubation (bacterial strains---35 °C for 24 h; yeast strains---30 °C for 48 h), the MICs were visually assessed as the lowest concentration of the extracts showing the complete growth inhibition of the reference microbial strains. An appropriate DMSO control (at a final concentration of 10%), a positive control (containing inoculum without the tested derivatives), and a negative control (containing the tested derivatives without inoculum) were included on each microplate. Minimal bactericidal concentration (MBC) or minimal fungicidal concentration (MFC) was determined by subculturing 5 μL of the microbial culture from each well that showed growth inhibition, from the last positive one and from the growth control onto the recommended agar plates. The plates were incubated at 35 °C for 24 h, and the MBC/MFC was defined as the lowest concentration of the extracts without the growth of microorganisms. Each experiment was repeated in triplicate. The highest MIC value was noted \[[@B53-molecules-25-03099]\].

4. Conclusions {#sec4-molecules-25-03099}
==============

In summary, three metal complexes of cobalt and nickel with mefenamato ligand were characterized by X-ray structure analysis combined with elemental and thermal analyses that were further augmented by spectroscopic and biological activity studies. The structure of **3** and **4** are stabilized by strong intermolecular hydrogen bonds of diverse topologies, thus yielding quasi-isostructural arrangements. Their crystal packing formation is reflected by the Hirshfeld surface analysis of intermolecular contacts. The latter shows subtle differences in the O^...^H contacts contributions, which are closely related to diverse hydrogen bonds topologies and thermal decomposition patterns, as observed in **3** and **4**. In particular, the higher contribution of O^...^H contacts prompts a single step of methanol molecule elimination. On the contrary, a two-stage elimination can be observed in **4**.

The antibacterial, antifungal, and antioxidant activities were determined for **2**--**4** and additionally for six complexes with mefenamic acid, namely **5**--**10**, the syntheses of which were recently published by us. All investigated complexes showed an antioxidant activity higher than that of mefenamic acid. The most promising antioxidant scavengers were **5** and **4**, with maximum actions of 42.0% and 38.2%, respectively. Additionally, the tested compounds exhibited moderate to strong activity against Gram-positive rods. Compounds **10**, **3**, **2**, and **6** were the most promising antibacterial agents. However, only **10** exhibited a significant antifungal bioactivity.

**Sample Availability:** Not available.

The supplementary material includes: Polymeric chain running along the \[100\] axis in **2** (Figure S1); Fragment of the intermolecular chain along \[100\] stabilized by hydrogen bonds, as in **3**(a) and **4**(b) (Figure S2); FTIR spectra of **2**--**4** (Figure S3). Bond distances for **2**, **3**, and **4** (Tables S1, S4, and S7, respectively); Bond angles for **2**, **3**, and **4** (Tables S2, S5 and S8, respectively); Torsion angles for **2**, **3** and **4** (Tables S3, S6 and S9, respectively).
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Figures, Scheme and Tables
==========================

![Structural schemes of **1**--**4**.](molecules-25-03099-sch001){#molecules-25-03099-sch001}

![The crystal structure of **2.** Hydrogen atoms are omitted for clarity. Displacement ellipsoids are drawn at the 50% probability level. Only the asymmetric unit is labeled, and the major component of disordered atoms are display for clarity.](molecules-25-03099-g001){#molecules-25-03099-f001}

![Molecular structures of **3**(a) and **4**(b). Hydrogen atoms are omitted for clarity. Displacement ellipsoids are drawn at the 50% probability level. Only asymmetric units are labeled.](molecules-25-03099-g002){#molecules-25-03099-f002}

![Superposition of structures **3** (red) and **4** (green). Hydrogen atoms and methanol O5 molecules in the outer coordination sphere are omitted for clarity.](molecules-25-03099-g003){#molecules-25-03099-f003}

![(**a**) Hirshfeld surfaces generated for the mer unit of **2** and the single molecules of **3** and **4**. (**b**) Fingerprint plots generated for respective moieties. Labels indicate regions of specific interatomic interactions. (**c**) The percentage contributions to the Hirshfeld surface areas for intermolecular contacts.](molecules-25-03099-g004){#molecules-25-03099-f004}

![Thermoanalytical curves for **2** (**a**), **3** (**b**), and **4** (**c**). TG is plotted in green, DTG is in blue, while DTA is in red.](molecules-25-03099-g005){#molecules-25-03099-f005}

![The radical scavenging activities for all complexes. Mefenamic acid (pale purple) is given as a reference.](molecules-25-03099-g006){#molecules-25-03099-f006}

molecules-25-03099-t001_Table 1

###### 

Analytical data for **2**--**4**.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.     Compounds                              Empirical Formula          Color        Formula Weight (g/mol)   Elemental Analysis, Found (calc.) (%)                     
  ------- -------------------------------------- -------------------------- ------------ ------------------------ --------------------------------------- -------- -------- --------
  **2**   \[Co~2~(mef)~4~(EtOH)~2~(H~2~O)~4~\]   C~64~H~74~Co~2~N~4~O~14~   pale pink    1241.16                  62.21\                                  5.87\    4.87\    9.96\
                                                                                                                  (61.93)                                 (6.01)   (4.51)   (9.50)

  **3**   \[Co(mef)~2~(MeOH)~4~\]∙2MeOH          C~36~H~52~CoN~2~O~10~      pink         731.72                   59.88\                                  7.02\    3.27\    8.78\
                                                                                                                  (59.09)                                 (7.16)   (3.83)   (8.05)

  **4**   \[Ni(mef)~2~(MeOH)~4~\]∙2MeOH          C~36~H~52~NiN~2~O~10~      pale green   731.50                   59.58\                                  7.61\    3.97\    8.48\
                                                                                                                  (59.11)                                 (7.17)   (3.83)   (8.02)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* M represents Co in **2** and **3** or Ni in **4**.

molecules-25-03099-t002_Table 2

###### 

Crystal data and structure refinement parameters for **2**--**4**.

                            2                    3                    4
  ------------------------- -------------------- -------------------- --------------------
  T (K)                     100.0                100                  100
  Crystal system            triclinic            triclinic            triclinic
  Space group               P$\overline{1}$      P$\overline{1}$      P$\overline{1}$
  a (Å)                     7.80610(10)          7.6291(2)            7.6176(2)
  b (Å)                     13.0847(4)           7.8052(2)            7.8118(4)
  c (Å)                     15.7219(5)           15.7376(3)           15.7014(3)
  α (°)                     105.091(3)           89.971(2)            89.966(3)
  β (°)                     97.760(2)            80.7510(10)          80.276(2)
  γ (°)                     97.208(3)            87.376(3)            87.349(3)
  *V* (Å^3^)                1514.45(7)           923.95(4)            919.91(6)
  Z                         2                    1                    1
  ρ~calc~ (g/cm^3^)         1.363                1.315                1.320
  F(000)                    654                  389                  390
  Radiation                 CuKα (λ = 1.54184)   MoKα (λ = 0.71073)   MoKα (λ = 0.71073)
  2*θ* range (°)            5.914--148.962       5.224--61.012        5.432--63.01
  Reflections collected     6987                 64201                45789
  Independent reflections   6134                 5622                 6094
  Goodness-of-Fit (GOF)     1.050                1.089                1.044
  R \[I ≥ 2σ (I)\]          0.0388               0.0347               0.0368
  *w*R~2~ \[I ≥ 2σ (I)\]    0.1027               0.0941               0.0953

molecules-25-03099-t003_Table 3

###### 

Hydrogen bond geometry in **2** (Å,°).

  D-H^...^A           D-H         H^...^A     D^...^A    D-H^...^A
  ------------------- ----------- ----------- ---------- -----------
  O6-H6A^...^O1 ^a^   0.83(2)     1.85(2)     2.672(2)   170(3)
  O7-H6^...^O3        0.83(3)     1.84(3)     2.670(2)   174(3)
  O5-H5B^...^O2       0.85(2)     1.74(2)     2.560(2)   161(2)
  O5-H5A^...^O4 ^b^   0.835(18)   1.723(19)   2.541(2)   166(2)
  N1-H1^...^O2        0.90(3)     1.87(3)     2.661(3)   145(3)
  N2A-H2A^...^O4      0.84(6)     1.94(5)     2.58(2)    132(6)

Symmetry codes: (^a^) −1+x, y, z; (^b^) 1−x, 1−y, −z.

molecules-25-03099-t004_Table 4

###### 

Hydrogen bond geometry in **3** (Å,°).

  D-H^...^A            D-H         H^...^A   D^...^A      D-H^...^A
  -------------------- ----------- --------- ------------ -----------
  N1A-H1A^...^O1       0.813(18)   1.95(2)   2.552(5)     130(2)
  O3A-H3A^...^O5A      0.72(3)     2.13(3)   2.835(5)     168(3)
  O4A-H4A^...^O2       0.92(3)     1.72(3)   2.6045(16)   162(3)
  O5B-H5B^...^O2 ^a^   0.82(6)     2.04(6)   2.676(11)    134(5)

Symmetry codes: (^a^) −1+x, y, z.

molecules-25-03099-t005_Table 5

###### 

Hydrogen bond geometry in **4** (Å,°).

  D-H^...^A            D-H       H^...^A     D^...^A      D-H^...^A
  -------------------- --------- ----------- ------------ -----------
  N2B-H2B^...^O1       0.83(2)   1.83(3)     2.521(6)     133(4)
  O3A-H3A^...^O2 ^a^   0.84(2)   1.772(19)   2.5989(17)   166(3)
  O4A-H4A^...^O5A      0.84(3)   1.86(3)     2.663(5)     161(4)
  O5A-H5A^...^O2 ^b^   0.83(7)   2.12(7)     2.732(6)     131(8)

Symmetry codes: (^a^) 1-x, 1-y, 1-z; (^b^) -1+x, y, z.

molecules-25-03099-t006_Table 6

###### 

The antibacterial and antifungal activities.

  ------------------------------ ---------------- ------- -------- ------- -------- ------- ------- ------- -------- --------- ------
  **Bacteria**                   **MIC (mg/L)**                                                                                
  **1**                          **2**            **3**   **4**    **5**   **6**    **7**   **8**   **9**   **10**   **Van**   
  *S. aureus* ATCC 25923         1000             125     125      125     250      125     125     250     125      62.5      0.98
  *S. epidermidis* ATCC 12228    \>1000           250     250      250     500      250     250     250     125      62.5      0.98
  *M. luteus* ATCC 10240         62.5             125     62.5     125     250      62.5    125     62.5    125      3.9       0.12
  *E. faecalis* ATCC 29212       \>1000           1000    \>1000   500     1000     500     500     1000    500      15.6      1.95
  *B. subtilis* ATCC 6633        62.5             125     62.5     125     250      125     125     125     125      7.8       0.24
  *B. cereus* ATCC 10876         62.5             62.5    62.5     125     125      62.5    125     62.5    62.5     62.5      0.98
  *S, pyogenes* ATCC 19615       125              125     62.5     62.5    250      31.3    125     125     250      31.3      0.24
  *S. pneumoniae* ATCC 49619     125              62.5    62.5     62.5    250      31.3    125     125     125      7.8       0.24
  *S. mutans* ATCC 25175         500              125     125      250     \>1000   125     50      250     250      15.6      0.98
  **Yeasts**                     **MIC (mg/L)**                                                                                
  **1**                          **2**            **3**   **4**    **5**   **6**    **7**   **8**   **9**   **10**   **Nys**   
  *C. albicans* ATCC 102231      1000             1000    1000     1000    500      1000    250     1000    500      250       0.48
  *C. parapsilosis* ATCC 22019   1000             1000    1000     1000    500      500     250     500     500      15.6      0.24
  *C. glabrata* ATCC 90030       1000             500     500      1000    250      500     500     1000    1000     125       0.24
  ------------------------------ ---------------- ------- -------- ------- -------- ------- ------- ------- -------- --------- ------
